| 2025 |
Werid, G. M., Ibrahim, Y. M., Girmay, G., Hemmatzadeh, F., Miller, D., Kirkwood, R., & Petrovski, K. (2025). Bovine adenovirus prevalence and its role in bovine respiratory disease complex: A systematic review and meta-analysis. Veterinary Journal, 310, 12 pages.
DOI Scopus1 |
| 2024 |
Werid, G. M., Van, T. D., Miller, D., Hemmatzadeh, F., Fulton, R. W., Kirkwood, R., & Petrovski, K. (2024). Bovine Parainfluenza-3 Virus Detection Methods and Prevalence in Cattle: A Systematic Review and Meta-Analysis. Animals, 14(3), 494-1-494-20.
DOI Scopus5 Europe PMC4 |
| 2024 |
Werid, G. M., Wubshet, A. K., Araya, T. T., Miller, D., Hemmatzadeh, F., Reichel, M. P., & Petrovski, K. (2024). Detection of Bovine Respiratory Syncytial Virus in Cattle: A Systematic Review and Meta-Analysis. Ruminants, 4(4), 491-514.
DOI |
| 2023 |
Werid, G. M., Hemmatzadeh, F., Miller, D., Reichel, M. P., Messele, Y. E., & Petrovski, K. (2023). Comparative Analysis of the Prevalence of Bovine Viral Diarrhea Virus in Cattle Populations Based on Detection Methods: A Systematic Review and Meta-Analysis. Pathogens, 12(8), 1067-1-1067-21.
DOI Scopus9 WoS1 Europe PMC3 |
| 2023 |
Werid, G. M., Miller, D., Hemmatzadeh, F., Messele, Y. E., & Petrovski, K. (2023). An overview of the detection of bovine respiratory disease complex pathogens using immunohistochemistry: emerging trends and opportunities. Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc, 36(1), 12-23.
DOI Scopus6 Europe PMC5 |
| 2019 |
Fabijan, J., Miller, D., Olagoke, O., Woolford, L., Boardman, W., Timms, P., . . . Speight, K. N. (2019). Prevalence and clinical significance of koala retrovirus in two South Australian koala (Phascolarctos cinereus) populations. Journal of Medical Microbiology, 68(7), 1072-1080.
DOI Scopus20 WoS18 Europe PMC16 |
| 2018 |
Olagoke, O., Miller, D., Hemmatzadeh, F., Stephenson, T., Fabijan, J., Hutt, P., . . . Timms, P. (2018). Induction of neutralizing antibody response against koala retrovirus (KoRV) and reduction in viral load in koalas following vaccination with recombinant KoRV envelope protein. npj Vaccines, 3(1), 30-1-30-8.
DOI Scopus18 WoS16 Europe PMC16 |
| 2015 |
Miller, D., Parsons, A., Bresland, J., Herde, P., Pham, D., Tan, A., . . . Butler, R. (2015). A simple and inexpensive enteric-coated capsule for delivery of acid-labile macromolecules to the small intestine. Journal of Zhejiang University. Science B, 16(7), 586-592.
DOI Scopus15 WoS10 Europe PMC8 |
| 2014 |
Garrod, T., Grubor-Bauk, B., Gargett, T., Li, Y., Miller, D., Yu, W., . . . Gowans, E. (2014). DNA vaccines encoding membrane-bound or secreted forms of heat shock protein 70 exhibit improved potency. European Journal of Immunology, 44(7), 1992-2002.
DOI Scopus23 WoS18 Europe PMC17 |
| 2014 |
Gargett, T., Grubor-Bauk, B., Garrod, T., Yu, W., Miller, D., Major, L., . . . Gowans, E. (2014). Induction of antigen-positive cell death by the expression of Perforin, but not DTa, from a DNA vaccine enhances the immune response. Immunology and Cell Biology, 92(4), 359-367.
DOI Scopus23 WoS23 Europe PMC22 |
| 2014 |
Gargett, T., Grubor-Bauk, B., Miller, D., Garrod, T., Yu, S., Wesselingh, S., . . . Gowans, E. (2014). Increase in DNA vaccine efficacy by virosome delivery and co-expression of a cytolytic protein. Clinical and Translational Immunology, 3(6), e18-1-e18-7.
DOI Scopus22 WoS16 Europe PMC17 |
| 2013 |
Farrow, N., Miller, D., Cmielewski, P., Donnelley, M., Bright, R., & Parsons, D. (2013). Airway gene transfer in a non-human primate: Lentiviral gene expression in marmoset lungs. Scientific Reports, 3(1), 1-3.
DOI Scopus24 WoS21 Europe PMC16 |
| 2013 |
Miller, D., Kok, T., & Li, P. (2013). The virus inoculum volume influences outcome of influenza A infection in mice. Laboratory Animals, 47(1), 74-77.
DOI Scopus28 WoS21 Europe PMC21 |
| 2012 |
Miller, D., Brown, M., Howley, P., & Hayball, J. (2012). Current and emerging immunotherapeutic approaches to treat and prevent peanut allergy. Expert Review of Vaccines, 11(12), 1471-1481.
DOI Scopus7 WoS6 Europe PMC5 |
| 2011 |
Miller, D., Finnie, J., Bowden, T., Scholz, A., Oh, S., Kok, T., . . . Li, P. (2011). Preclinical efficacy studies of Influenza A haemagglutinin precursor cleavage loop peptides as a potential vaccine. Journal of General Virology, 92(5), 1152-1161.
DOI Scopus14 WoS12 Europe PMC9 |
| 2010 |
Liu, C., Wong, E., Miller, D., Smith, G., Anson, D., & Parsons, D. (2010). Lentiviral airway gene transfer in lungs of mice and sheep: successes and challenges. Journal of Gene Medicine, 12(8), 647-658.
DOI Scopus17 WoS16 Europe PMC10 |
| 2009 |
Stocker, A., Kremer, K., Koldej, R., Miller, D., Anson, D., & Parsons, D. (2009). Single-dose lentiviral gene transfer for lifetime airway gene expression. Journal of Gene Medicine, 11(10), 861-867.
DOI Scopus61 WoS56 Europe PMC46 |
| 2008 |
Miller, D., Boyle, D., Feng, F., Reaiche-Miller, G., Kotlarski, I., Colonno, R., & Jilbert, A. (2008). Antiviral therapy with entecavir combined with post-exposure “prime-boost” vaccination eliminates duck hepatitis B virus-infected hepatocytes and prevents the development of persistent infection. Virology, 373(2), 329-341.
DOI Scopus13 WoS9 Europe PMC7 |
| 2006 |
Tsopelas, C., Penglis, P., Miller, D., Rischmueller, M., & Bartholomeusz, F. (2006). Evaluation of Tc-99m-immunoglobulins for imaging infection in the rat. Journal of Labelled Compounds & Radiopharmaceuticals, 49(10), 915-928.
DOI Scopus2 WoS1 |
| 2006 |
Miller, D., Kotlarski, I., & Jilbert, A. (2006). DNA vaccines expressing the duck hepatitis B virus surface proteins lead to reduced numbers of infected hepatocytes and protect ducks against the development of chronic infection in a virus dose-dependent manner. Virology, 351(1), 159-169.
DOI Scopus9 WoS6 Europe PMC7 |
| 2006 |
Miller, D., Halpern, M., Kotlarski, I., & Jilbert, A. (2006). Vaccination of ducks with a whole-cell vaccine expressing duck hepatitis B virus core antigen elicits antiviral immune responses that enable rapid resolution of de novo infection. Virology, 348(2), 297-308.
DOI Scopus8 WoS7 Europe PMC6 |
| 2005 |
Guo, H., Mason, W., Aldrich, C., Saputelli, J., Miller, D., Jilbert, A., & Newbold, J. (2005). Identification and characterization of avihepadnaviruses isolated from exotic anseriformes maintained in captivity. Journal of Virology, 79(5), 2729-2742.
DOI Scopus66 WoS43 Europe PMC42 |
| 2005 |
Foster, W., Miller, D., Scougall, C., Kotlarski, I., Colonno, R., & Jilbert, A. (2005). Effect of antiviral treatment with entecavir on age- and dose-related outcomes of duck hepatitis B virus infection. Journal of Virology, 79(9), 5819-5832.
DOI Scopus31 WoS25 Europe PMC23 |
| 2005 |
Le Mire, M., Miller, D., Foster, W., Burrell, C., & Jilbert, A. (2005). Covalently closed circular DNA is the predominant form of duck hepatitis B virus DNA that persists following transient infection. Journal of Virology, 79(19), 12242-12252.
DOI Scopus37 WoS27 Europe PMC22 |
| 2004 |
Zhu, Y., Cullen, J., Aldrich, C., Saputelli, J., Miller, D., Seeger, C., . . . Jilbert, A. (2004). Adenovirus-based gene therapy during clevudine treatment of woodchucks chronically infected with woodchuck hepatitis virus. Virology, 327(1), 26-40.
DOI Scopus20 WoS16 Europe PMC15 |
| 2004 |
Miller, D., Bertram, E., Scougall, C., Kotlarski, I., & Jilbert, A. (2004). Studying host immune responses against duck Hepatitis B virus infection. Methods in Molecular Medicine, 96, 3-25.
DOI Scopus20 Europe PMC12 |
| 2003 |
Foster, W., Miller, D., Marion, P., Colonno, R., Kotlarski, I., & Jilbert, A. (2003). Entecavir therapy combined with DNA vaccination for persistent duck hepatitis B virus infection. Antimicrobial Agents and Chemotherapy, 47(8), 2624-2635.
DOI Scopus48 WoS40 Europe PMC35 |
| 2001 |
Zhu, Y., Yamamoto, T., Cullen, J., Saputelli, J., Aldrich, C., Miller, D., . . . Mason, W. (2001). Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis. Journal of Virology, 75(1), 311-322.
DOI Scopus210 WoS182 Europe PMC175 |
| 1998 |
Jilbert, A., Botten, J., Miller, D., Bertram, E., de la M. Hall, P., Kotlarski, I., & Burrell, C. (1998). Characterization of age- and dose-related outcomes of duck hepatitis B virus infection. Virology, 244(2), 273-282.
DOI Scopus78 WoS68 Europe PMC54 |
| 1998 |
Triyatni, M., Jilbert, A., Qiao, M., Miller, D., & Burrell, C. (1998). Protective efficacy of DNA vaccines against duck hepatitis B virus infection.. Journal of Virology, 72(1), 84-94.
DOI Scopus71 WoS59 Europe PMC42 |
| 1998 |
Mason, W. S., Cullen, J., Moraleda, G., Saputelli, J., Aldrich, C. E., Miller, D. S., . . . Jilbert, A. R. (1998). Lamivudine therapy of WHV-infected woodchucks. Virology, 245(1), 18-32.
DOI Scopus151 WoS137 Europe PMC112 |
| 1996 |
Jilbert, A., Miller, D., Scougall, C., Turnbull, H., & Burrell, C. (1996). Kinetics of duck hepatitis B virus infection following low dose virus inoculation: One virus DNA genome is infectious in neonatal ducks. Virology, 226(2), 338-345.
DOI Scopus96 WoS86 Europe PMC69 |
